Pharmafile Logo
Pharmafocus logo
Advanced Search
dna_research

Link discovered between immune system genes and leukaemia

February 6, 2017
Research and Development, Sales and Marketing Bloodwise, ICR, leukaemia

Research coming out of The Institute of Cancer Research, and funded by charity Bloodwise, has found that people who inherit …

News
innate-pharma

Phase 2 failure for Innate Pharma leukaemia drug

February 6, 2017
Research and Development, Sales and Marketing Innate Pharma, leukaemia, lirilumab

Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …

News
computer_doctor

10% of UK left with no out-of-hours GP cover during 2016

February 6, 2017
Medical Communications, Sales and Marketing

A freedom of information request, by Pulse, led to the discovery that 1 in 10 areas in the UK were …

News
cancer-389921_960_720

Cancer rates set to rocket in women six times faster than men

February 3, 2017
Medical Communications, Research and Development Cancer, Cancer Research UK, World Cancer Day

The figures emerging from research conducted by Cancer Research UK predict that rates of cancer in women will rise by …

News
r3ws8b7e-web

Takeda discusses the importance of patient-focused market access

February 3, 2017
Medical Communications, Sales and Marketing Takeda, oncology

With World Cancer Day on 4 February, Takeda Oncology’s Liviu Niculescu and Stephen J. Noga talk to Pharmafile.com on the …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Moving into February,and the first weeks of Trump’s term, the US President has dominated the headlines in the industry as …

News
pills

Study reveals antidepressant medication’s action upon brain

February 3, 2017
Medical Communications, Research and Development antidepressants, mental health, research

With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …

News
shutterstock_57369385

WCO seizes 113m fake Indian & Chinese drugs in Africa in 10 days

February 3, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Africa, China, Counterfeit drugs, India, World Customs Organisation

The World Customs Organisation (WCO) has revealed insight into the extent of the global drug counterfeiting crisis with the announcement …

News

NICE rejects Pfizer’s first-in-class breast cancer drug

February 3, 2017
Medical Communications, Sales and Marketing NICE, Pfizer, breast cancer

NICE has published draft guidelines which reject Pfizer’s Ibrance (palbociclib) based primarily on the cost of the drug but also …

News

Cirrus ready for serialisation pack changes

February 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cirrus, Multi Packaging Solutions

Cirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending …

News
Press release
heart_rope

More at risk of sudden death due to faulty heart gene than thought

February 2, 2017
Medical Communications, Research and Development British Heart Foundation, faulty gene, sudden death

The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …

News
insider_interview_headshots_2016_overview

2016: A retrospective from the industry

February 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

2016 was characterised by some of the biggest political shifts in recent times. We ask four major pharma figures for …

Feature

Pakistan drug regulatory body “a complete failure” according to officials

February 2, 2017
Sales and Marketing Drug Regulatory Authority of Pakistan, Pakistan, Sania Nishtar

Key figures in the Pakistani pharmaceutical industry are calling for review of the Drug Regulatory Authority of Pakistan (DRAP) over …

News
syringe-1973129_960_720

‘Last-resort’ antibiotic-resistant bacteria found along 4km of Chinese coastline

February 2, 2017
Medical Communications, Research and Development

Recent research has been published that reveals that a four kilometre stretch of coastline in China harboured bacteria resistant to …

News
allerganlogo

Allergan successfully completes $2.9bn LifeCell acquisition

February 2, 2017
Business Services, Sales and Marketing Allergan, LifeCell

The acquisition of regenerative medicine firm LifeCell by Allergan for $2.9 billion announced back in December has been completely successfully, …

News

Two-decade-long prostate cancer study finds antiandrogen improves survival

February 2, 2017
Research and Development antiandrogen, oncology, prostate cancer

Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …

News
rick_fair

Genentech oncology head leaves for Bellicum CEO role

February 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bellicum, Genentech, Roche, tecentriq

Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …

Appointment
msd_merck_night_building

MSD’s drug given European approval for first-line treatment in NSCLC

February 1, 2017
Sales and Marketing European Commission, MSD, Merck

The good news keeps coming for MSD, known as Merck in North America, and Keytruda, with a further label expansion …

News

Sanofi & Regeneron’s arthritis drug scores first approval following FDA rejection

February 1, 2017
Research and Development, Sales and Marketing Actemra, Humira, Kevzara, Regeneron, Roche, Sanofi, sarilumab

Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …

News
pills_spill

Potential treatment for opioid withdrawal discovered

February 1, 2017
Medical Communications, Research and Development University of Calgary, gout, opioid

Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026